摘要
目的回顾性分析我院超全视网膜光凝术(E-PRP)治疗高危增生性糖尿病视网膜病变(PDR)的效果与技术选择。方法对我院2007年1月至2008年6月间60例(95只眼)PDR进行E-PRD治疗,随诊6~30个月,对其进行疗效观察。结果高危PDR治疗视力提高22只眼,占23.16%,视力不变53只眼,占55.79%,视力下降20只眼,占21.05%。高危PDR治疗后新生血管完全消退29只眼,占30.52%,部分消退45只眼,占47.36%,不退或增加21只眼,占22.12%,出血吸收的总有效率为79.88%。结论高危PDR必须及时行E-PRP治疗。关键在于掌握激光的范围、光斑密度,使用达到Ⅲ级光斑的功率。
Objective To retrospectively study effect and technique of E-Panretinal photocoagulation(E-PRP ) treatment of proliferative diabetic retinopathy ( PDR ). Method 60 patients ( 90eyes ) with PDR recieved E-PRP trentment from January 2007 to June 2008,we evaluate the treatment effects after 6 - 30 months' s follow-up. Results On E-PRP treating PDR,22 eyes' s visual acuity increased( 23.16% ) ,53 eyes' s visual acuity unchanged(47.36% ) ,20 eyes' s visu- al acuity decreased ( 21.05% ). on E-PRP treating new vessels ( NV ) of PDR, 29 eyes ' s NV disappeared (30. 52% ), 45 eyes' s NV disappeared partially (47.36%), 21 eyes' s NV unchanged or increased ( 22.12% ), the rate of blood absorption is 79.88%. Conclusion E-PRP should be used in the treatment of PDR in time. We must pay attention to laser circumsciption, laser spot density and power in the treatment.
出处
《临床眼科杂志》
2010年第1期23-25,共3页
Journal of Clinical Ophthalmology